ATI RN
ATI RN Pharmacology 2023 II Questions
Extract:
Question 1 of 5
A nurse is assessing a client who is taking phenelzine and reports eating aged cheese. Which of the following is a manifestation of an interaction between the medication and the food?
Correct Answer: A
Rationale: The correct answer is A: Hypertension. Phenelzine is a monoamine oxidase inhibitor (MAOI) that can interact with tyramine-rich foods like aged cheese, leading to a hypertensive crisis. Tyramine can displace norepinephrine from nerve terminals, causing a sudden release of norepinephrine, resulting in increased blood pressure. Options B, C, and D are incorrect as they are not typically associated with MAOI and tyramine interaction. Diarrhea is more commonly seen with other medications. Bradycardia is not a typical manifestation of this interaction. Somnolence is a common side effect of phenelzine but not specifically related to the interaction with aged cheese.
Question 2 of 5
A nurse is planning care for a group of clients. Which of the following client's medications should be monitored by the nurse for hearing loss related to a medication interaction?
Correct Answer: B
Rationale: The correct answer is B: Furosemide and amikacin. Furosemide is a loop diuretic known to cause ototoxicity (hearing loss) and when combined with amikacin, an aminoglycoside antibiotic also known to cause ototoxicity, the risk of hearing loss is increased. Digoxin (
A) is associated with visual disturbances, not hearing loss. Losartan and atorvastatin (
C) are not known to cause hearing loss. Propranolol and raloxifene (
D) do not have ototoxic effects.
Question 3 of 5
A nurse is assessing a client who has septic shock and is receiving dopamine by continuous IV infusion. Which of the following findings indicates that the nurse should increase the rate of infusion?
Correct Answer: B
Rationale: The correct answer is B: Hypotension. In septic shock, dopamine is used to increase blood pressure. Hypotension indicates that the current dosage is not effectively managing the client's blood pressure, necessitating an increase in the infusion rate to achieve the desired therapeutic effect. Headache (choice
A) is a common side effect of dopamine but does not directly correlate with the need for a dosage increase. Chest pain (choice
C) may indicate other issues but does not specifically warrant a change in dopamine infusion rate. Extravasation (choice
D) refers to the leakage of IV fluid into the surrounding tissue and requires immediate attention but is not directly related to adjusting the infusion rate of dopamine.
Question 4 of 5
A nurse is caring for a client who is taking warfarin and reports taking several new herbal supplements. The nurse should identify that which of the following supplements is contraindicated for concurrent use with warfarin?
Correct Answer: C
Rationale: The correct answer is C: Ginkgo biloba. Ginkgo biloba can increase the risk of bleeding when taken with warfarin due to its anticoagulant properties. Warfarin also acts as a blood thinner, so combining it with Ginkgo biloba can lead to excessive bleeding. Valerian (
A) and Coenzyme Q10 (
D) are not known to interact significantly with warfarin. Probiotics (
B) are generally safe to use with warfarin and may even have beneficial effects on gut health.
Question 5 of 5
A nurse is planning to administer a prefilled syringe of enoxaparin to a client. Which of the following actions should the nurse take?
Correct Answer: B
Rationale: The correct answer is B: Administer the medication into the anterolateral or posterolateral abdominal area. Enoxaparin is a low molecular weight heparin that should be injected subcutaneously into the fatty tissue in the abdomen. This area has a good blood supply, allowing for better absorption of the medication. The nurse should choose an area away from the umbilicus and any scar tissue to prevent discomfort and ensure proper absorption. Massaging the injection site after administering the medication (
Choice
A) is not recommended as it can cause bruising and discomfort. Holding the skin taut at the injection site (
Choice
C) is unnecessary and may increase the risk of injecting the medication too deeply. Expelling the air bubble from the syringe (
Choice
D) is not necessary for subcutaneous injections and may lead to medication wastage.